Registered Nurse in Middleton, MA Accepting Medicare
11 Registered Nurse nurses found. Showing 1 - 11
 Nell Winchell Divincenzo, NP Registered Nurse Medicare: Medicare Enrolled Practice Location: 147 S Main St, Middleton, MA 01949 Phone: 978-774-2555 |
Mrs. Bridget Fonseca, RN Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 20 Manning Rd, Middleton, MA 01949 Phone: 978-750-1900 |
Shannon Savage, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 147 S Main St, Middleton, MA 01949 Phone: 978-774-2555 |
Mrs. Jenna Marie Poel, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 122 Essex St, Middleton, MA 01949 Phone: 978-490-6187 |
Pamela Blaise Asiimwe, CNP Registered Nurse - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 33 Gregory St, Middleton, MA 01949 Phone: 978-601-5926 |
Katlyn Jean Noonan, NP Registered Nurse Medicare: Medicare Enrolled Practice Location: 147 S Main St, Middleton, MA 01949 Phone: 978-774-2555 |
Katherine Mary Breslin, RN, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 67 School St, Middleton, MA 01949 Phone: 978-866-9341 |
Leah Wilkocki, Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 15 Ogden Ln, Middleton, MA 01949 Phone: 617-257-6836 |
Bianca Venezia Gonynor, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 36 Mount Vernon St, Middleton, MA 01949 Phone: 978-907-3662 |
Mrs. Carrie Marie Richardson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 Forest St, Middleton, MA 01949 Phone: 978-775-5850 |
Mrs. Randy Melina Musto, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Maplewood Rd, Middleton, MA 01949 Phone: 978-595-4113 |
News Archive
Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
Non-Caucasians at higher risk for severe metastatic breast cancer pain
A new study finds significant racial differences in the risk of pain related to metastatic breast cancer.
Changes in intestinal microbiota linked to primary sclerosing cholangitis
Primary sclerosing cholangitis, also known as PSC, is a liver disease with no effective medical treatment. Liver transplantation is the only proven long-term treatment of PSC, although only a fraction of individuals with PSC will ultimately require it.
Gallup, Healthways reveal new data on chronic disease burden of UK
Gallup, the global polling organization, and Healthways, the worldwide leader in well-being improvement, today jointly revealed new data showing that chronic conditions, such as obesity, diabetes and cancer are costing the UK economy 21.6 billion pounds a year in lost productivity.
› Verified 6 days ago